Bioreactors Market Overview and Introduction

The device used to carry out biological reactions is termed as a bioreactor.They are sterile vessels equipped with temperature controllers and gassing facilities required for starting a biochemical reaction. Control over temperature, moisture, pH level, oxygen levels and stirring rates yield the most suitable conditions necessary for maximized cell growth and productivity.Bioreactorsmimic a natural biochemical environment for the optimum growth of cells or tissues in microbial and cell culture.

The global bioreactors marketis majorly driven by the rapid growth in the pharmaceutical and biotechnology industries. According to The International Trade Administration (ITA), The U.S. is the largest market for biopharmaceuticals, accounting for around one-third of the global market and is the world leader in biopharmaceutical R&D. The growing popularity of single-use bioreactors in different biopharmaceutical companies and increasing investments in the R&D of innovative drugs to cope up with the rising demand for different diseases will boost market growth.According to the Pharmaceutical Research and Manufacturers Association (PhRMA), firms in the U.S. conduct over half the world's R&D in pharmaceuticals and hold the intellectual property rights on most new medicines. The overall economic impact of the biopharmaceutical industry on the U.S. economy is substantial. These factorsare anticipated to propel market growth during the forecast period. However, availability and access to various alternative techniques for bioreactors usedmight hinder the market growth to a certain extent.

The global bioreactors market has been segmented into the following categories -type, usage, scale,and end-user.

Bioreactors Market By Type

Based ontype, themarket can beclassified into single-use, stainless steel, glass, and others. Single-use bioreactors willdominate the market during the forecast period due to the widespread applications of these bioreactors across clinical and commercial production.

Bioreactors Market By Usage

Based onusage, themarket can be classified into lab-scale production, pilot-scale production, and full-scale production. Pilot-scale production bioreactors accounted for the largest market share owing to the design of these bioreactors, which check for any challenges before moving to laboratory scale production. These bioreactors are used for the production of mAbs, vaccines, recombinant proteins, and cell and gene therapy applications.

Bioreactors Market By Scale

Based onscale, the market can be classified into 5L-20L, 20L-200L, 200L-1500L, and above 1500L. 5L-20L scale bioreactors dominated the market owing to the growingdemand for intermediate-scale vessels for process development, scale-down troubleshooting or debottlenecking, generating characterization quantities of protein, and cell culture seed generation.

Bioreactors Market By End User

Based onend user the market can be classified into biopharmaceutical companies/manufacturers, R&D institutes/departments, and others. The biopharmaceutical companies/manufacturerssegment held the dominant share owing to increasedR&D investments to produce innovative products for the different diseases around the globe.

Bioreactors Market By Region

Based on the region, the global bioreactors marketcan be segmented into North America, Europe, Asia Pacific, and the Rest of the World (ROW).North America dominated the marketowing to thepresence of major biopharmaceutical manufacturing companies in the region alongwith government funding for R&D activities. Moreover, increased incidences of diseases, such as diabetes and cancers, are the factors contributing to the overall market growth in North America.

Bioreactors Market Prominent Players

Some of the key players operating in theglobal bioreactors market include Sartorius AG, Merck KGaA,

Thermo Fisher Scientific Inc., Danaher., Eppendorf AG, Applikon Biotechnology B.V., Celltainer,

Cellexus Ltd, Pall Corporation., Infors AG,and others.